Unexpected Pregnancy in a Patient with NMOSD after Treatment with Inebilizumab: A Case Report (P2-2.005)

Feiyan Wan; Xia Wu; Yuqin Tan; Y Guo; Yuge Wang; Wei Qiu; Li Xiao

doi:10.1212/wnl.0000000000216704

June 9, 2026Neurology

Unexpected Pregnancy in a Patient with NMOSD after Treatment with Inebilizumab: A Case Report (P2-2.005)

View Full Paper

Ask AI

Bookmark

Share

Key Points

This report aims to explore the implications of inebilizumab treatment in pregnant patients with NMOSD, focusing on both maternal and fetal outcomes.
Case report detailing the use of inebilizumab in a patient with NMOSD during pregnancy.
Assessment of long-term outcomes for mother, fetus, and disease post-treatment.
Documented pregnancy occurrence in a patient treated with inebilizumab.
Provided insights on the health outcomes of both mother and fetus post-treatment.

Implication

Case report examines inebilizumab effects on pregnancy and outcomes for NMOSD patients, suggesting key insights.

Abstract

To fill the evidence gap regarding the use of inebilizumab in pregnant patients with neuromyelitis optica spectrum disorder (NMOSD) and provide detailed data on its application as well as the long-term outcomes for mothers, fetuses, and the disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wan et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf36efaef96ed7f055f1d https://doi.org/10.1212/wnl.0000000000216704

View Full Paper

Ask AI

Bookmark

Share

Unexpected Pregnancy in a Patient with NMOSD after Treatment with Inebilizumab: A Case Report (P2-2.005)

Key Points

Implication

Abstract

Discussion

Cite This Study

Unexpected Pregnancy in a Patient with NMOSD after Treatment with Inebilizumab: A Case Report (P2-2.005)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading